Enhancement of graft-versus-tumor activity and graft-versus-host disease by pretransplant immunization of allogeneic bone marrow donors with a recipient-derived tumor cell vaccine

Cancer Research

Volumn 59, Issue 7, 1999, Pages 1525-1530

  Anderson Jr , Larry D ^a   Petropoulos, Demetrios ^a   Everse, Linda A ^a   Mullen, Craig A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR CELL VACCINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER IMMUNOTHERAPY; CANCER TRANSPLANTATION; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; IMMUNOSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BONE MARROW TRANSPLANTATION; CANCER VACCINES; FEMALE; GRAFT VS HOST DISEASE; GRAFT VS TUMOR EFFECT; IMMUNIZATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HOMOLOGOUS;

EID: 0345003920     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Wojtowicz-Praga, S. Reversal of tumor-induced immunosuppression: a new approach to cancer therapy. J. Immunother., 20: 165-177, 1997.
2. Mullen, C. A., Urban, J. L., Van Waes, C., Rowley, D. A. and Schreiber, H. Multiple cancers. Tumor burden permits the outgrowth of other cancers. J. Exp. Med., 162: 1665-1682, 1985.
3. Mackall, C. L., Fleisher, T. A., Brown, M. R., Magrath, I. T., Shad, A. T., Horowitz, M. E., Wexler, L. H., Adde, M. A., McClure, L. L., and Gress, R. E. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood, 84: 2221-2228, 1994.
4. Mackall, C. L., Fleisher, T. A., Brown, M. R., Andrich, M. P., Chen, C. C., Feuerstein, I. M., Horowitz, M. E., Magrath, I. T., Shad, A. T., Steinberg, S. M., Wexler, L. H., and Gress, R. E. Age, thymopoiesis, and CD4+ T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med., 332: 143-149, 1995.
5. Talmadge, J. E., Jackson, J. D., Borgeson, C. D., and Perry, G. A. Differential recovery of polymorphonuclear neutrophils, B and T cell subpopulations in the thymus, bone marrow, spleen and blood of mice following split-dose polychemotherapy. Cancer Immunol. Immunother., 39: 56-67, 1994.
6. Morgenstern, J. P., and Land, H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res., 18: 3587-3596, 1990.
7. Weiden, P. L., Sullivan, K. M., Flournoy, N., Storb, R., and Thomas, E. D. Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation. N. Engl. J. Med., 304: 1529-1533, 1981.
8. Sullivan, K. M., Storb, R., Buckner, C. D., Fefer, A., Fisher, L., Weiden, P. L. X., Witherspoon R. P., Appelbaum, F. R., Banaji, M., Hansen, J., Martin, P., Sanders, J. E., Singer, J., and Thomas, E. D. Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N. Engl. J. Med., 320: 828-834, 1989.
9. Goulmy, E. Human minor histocompatibility antigens. Curr. Opin. Immunol., 8: 75-81, 1996.
10. de Bueger, M., Bakker, A., Van Rood, J. J., Van der Woude, F., and Goulmy, E. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens. J. Immunol., 149: 1788-1794, 1992.
11. Horowitz, M. M., Gale, R. P., Sondel, P. M., Goldman, J. M., Kersey, J., Kolb, H. J., Rimm, A. A., Ringden, O., Rozman, C., Speck, B., Truitt, R. L. Zwaan, F. E., and Bortin, M. M. Graft-versus-leukemia reactions after bone marrow transplantation. Blood, 75: 555-562, 1990.
12. Glass, B., Uharek, L., Gassmann, W., Focks, B., Bolouri, H., Loeffler, H., and Mueller-Ruchholtz, W. Graft-versus-leukemia activity after bone marrow transplantation does not require graft-versus-host disease. Ann. Hematol., 64: 255-259, 1992.
13. van Lochem, E., de Gast, B., and Goulmy, E. In vitro separation of host specific graft-versus-host and graft-versus-leukemia cytotoxic T cell activities. Bone Marrow Transplant., 10: 181-183, 1992.
14. Hoffmann, T., Theobald, M., Bunjes, D., Weiss, M., Heimpel, H., and Heit, W. Frequency of bone marrow T cells responding to HLA-identical non-leukemic and leukemic stimulator cells. Bone Marrow Transplant., 12: 1-8, 1993.
15. Datta, A. R., Barrett, A. J., Jiang, Y. Z., Guimaraes, A., Mavroudis, D. A., van Rhee, F., Gordon, A. A., and Madrigal, A. Distinct T cell populations distinguish chronic myeloid leukaemia cells from lymphocytes in the same individual: a model for separating GVHD from GVL reactions. Bone Marrow Transplant., 14: 517-524, 1994.
16. Gale, R. P., Sparkes, R. S., and Golde, D. W. Bone marrow origin of hepatic macrophages (Kuppfer cells) in humans. Science (Washington DC), 201: 937-938, 1978.
17. Katz, S. I., Tamaki, K., and Sachs, D. H. Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature (Lond.), 282: 324-326, 1979.
18. Restifo, N. P., Esquivel, F., Asher, A. L., Stotter, H., Barth, R. J., Bennink, J. R., Mule, J. J., Yewdell, J. W., and Rosenberg, S. A. Defective presentation of endogenous antigens by a murine sarcoma. Implications for the failure of an anti-tumor immune response. J. Immunol., 147: 1453-1459, 1991.
19. Guinan, E. C., Gribben, J. G., Boussiotis, V. A., Freeman, G. J., and Nadler, L. M. Pivotal role of the B7:CD28 pathway in transplantation tolerance and tumor immunity. Blood, 84: 3261-3282, 1994.
20. Miller, A. D., and Rosman, G. J. Improved retroviral vectors for gene transfer and expression. Biotechniques, 7: 980-990, 1989.
21. Mullen, C. A., Anderson, L., Woods, K., Nishino, M., and Petropoulos, D. Ganciclovir chemoabtation of herpes thymidine kinase suicide gene-modified tumors produces tumor necrosis and induces systemic immune responses. Hum. Gene Ther., 9: 2019-2030, 1998.
22. Kaminski, E., Hows, J., Goldman, J., and Batchelor, R. Optimising a limiting dilution culture system for quantitating frequencies of alloreactive cytotoxic T lymphocyte precursors. Cell. Immunol., 137: 88-95, 1991.
23. Sharrock, C. E., Kaminski, E., and Man, S. Limiting dilution analysis of human T cells: a useful clinical tool. Immunol. Today, 11: 281-286, 1990.
24. Mullen, C. A., Coale, M. M., Lowe, R., and Blaese, R. M. Tumors expressing the cylosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild-type tumor. Cancer Res., 54: 1503-1506, 1994.
25. Mullen, C. A., Petropoulos, D., and Lowe, R. M. Treatment of microscopic pulmonary metastases with recombinant autologous tumor vaccine expressing interleukin 6 and Escherichia coli cytosine deaminase suicide genes. Cancer Res., 56: 1361-1366, 1996.
26. Morecki, S., Yacovlev, E., Diab, A., and Slavin, S. Allogeneic cell therapy for a murine mammary carcinoma. Cancer Res., 58: 3891-3895, 1998.
27. Korngold, R., Leighton, C., and Manser, T. Graft-versus-myeloid leukemia responses following syngeneic and allogeneic bone marrow transplantation. Transplantation (Baltimore), 58: 278-287, 1994.
28. Champlin, R., Ho, W., Gajewski, J., Feig, S., Burnison, M., Holley, G., Greenberg, P., Lee, K., Schmid, I., Giorgi, J., Yam, P., Petz, L., Winston, D., Warner, D., and Reichert, T. Selective depletion of CD8+ T lymphocytes for prevention of graft-versus-host disease after allogeneic bone marrow transplantation. Blood, 76: 418-423, 1990.
29. Rosenberg, S. A. Cancer vaccines based on the identification of genes encoding cancer regression antigens. Immunol. Today, 18: 175-182, 1997.
30. Van den Eynde, B. J., and Boon, T. Tumor antigens recognized by T lymphocytes. Int. J. Clin. Lab. Res., 27: 81-86, 1997.